News

Jane Mast, PhD, DMSc, MPAS, discusses empathetic care in hidradenitis suppurativa and the importance of supporting patients with HS in every step of their journey with the condition.

Arash Mostaghimi, MD, MPA, MPH, provides a comprehensive overview of his SDPA conference sessions, "Understanding the Pathology Report and Basic Biopsies," "Beyond the H&E," and "Alopecia: Treating Challenging Cases."

The drug also demonstrated efficacy in improving sleep quality and reducing sleep disruption.

In recognition of World Vitiligo Day, the Dermatology Times team is spotlighting advances and educational opportunities for the condition.

Melodie Young, MSN, ANP-c, shares pearls on why prioritizing skin checks during Psoriasis Action Month in August is critical.

Catch up on coverage from the third day of the 2023 SDPA Annual Summer Dermatology Conference.

Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.

Megan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.

Joslyn Kirby, MD, discusses the importance of awareness and recognition in hidradenitis suppurativa from a clinician and patient perspective.

A poster presented at the SDPA Annual Summer Dermatology Conference revealed the abrocitinib did not have a significant impact on adolescent immune responses to Tdap vaccination.

With bimekizumab, the conservative imputation method led to higher response rates, achieved endpoints, and blocked IL-17A and IL-17F.

The National Psoriasis Foundation found that patients were frustrated by a lack of treatment options.

In a Maui Derm NP+PA Summer poster presentation, investigators revealed that treatment with spesolimab resulted in a reduction of lesions.

Catch up on coverage from the second day of the 2023 SDPA Annual Summer Dermatology Conference.

Over 24 weeks, dupilumab demonstrated efficacy in patients with chronic spontaneous urticaria.

Renata Block, MMS, PA-C, talks about the role of physician assistants in dermatology and related organizations in supporting PAs.

In the case of one patient, researchers found that topical tapinarof cream demonstrated therapeutic efficacy in nonulcerated necrobiosis lipoidica.

John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"

Darrell Rigel, MD, discusses his SDPA Annual Summer Dermatology Conference, "Inflammatory Dermatoses: A Case-Based Review," particularly highlighting the relationship between skin cancer and the inflammatory disease realm.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference analyzed the growing threat of antifungal resistance, particularly with the treatment of onychomycosis in mind.

Nicole Gunasekera, MD, MBA, presented a session on disorders of pigmentation at the 2023 SDPA Annual Summer Dermatology Conference.

Researchers evaluated factors affecting quality of life and what to consider when determining a patient’s psoriasis treatment plan.

In part 2 of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses safe and effective skin care products for infants.

Catch up on coverage from the first day of the 2023 SDPA Annual Summer Dermatology Conference.

Catch up on visual highlights and views from the first day of the SDPA Annual Summer Dermatology Conference in Boston, MA.

Mark Lebwohl, MD, discusses his SDPA Annual Summer Dermatology Conference session, "Inflammatory Dermatoses: A Case-Based Review."

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.

Omar Noor, MD, FAAD, discusses cultural competency in caring for patients with skin of color in dermatology.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed statistically significant improvements among patients with psoriasis receiving brodalumab treatment.